Showing results for "l nicklin"
Showing 1 - 1 of 1 Results
Adult content is visible.
Progress in Immunology
Vol. VII: Proceedings of the 7th International Congress Immunology Berlin 1989
2012
EN
Never has so much progress been reported in immunology as at this congress. The full impact of new technologies, developed since the late 1970s, has come to fruition: gene isolation, mutation, transfection and expression, protein structure and peptide synthesis, cell cloning, hybridization and monoclonal antibodies, CD serology, SCID and transgenic mice, modern immunomudulation and vaccines. An overwhelming mass of data has accumulated over the last years. The reports are up-to-date and ou...
$99.39 CAD
People who read this also enjoyed
Immunology
Volume 1: Immunotoxicology, Immunopathology, and Immunotherapy
2017
EN
Accessible
Immunology, Volume 1: Immunotoxicology, Immunopathology, and Immunotherapy discusses the investment of time, effort and finance that go into making progress in preventing and/or curing serious diseases by using standard treatments (chemotherapy, radiotherapy, surgery, and hormone therapy). The use of these treatments is accompanied by unavoidable, devastating side effects. At the cost of being repetitious, it has to be emphasized that an improved understanding of the immune system, avoidan...
$187.99 CAD
- Series -
- Biomedical and Life Sciences (R0)
2016
EN
To celebrate the 40th anniversary of the discovery of Natural Killer (NK) cells, this volume focuses on the recent advances in our understanding of NK cell development and differentiation and their acquisition of functional properties, as well as the latest models for NK-cell analysis in mice and applications in clinical medicine. NK cells have travelled a circuitous path from their initial description as ‘spontaneous killers’ (for some simply an experimental artifact) to being a bona ...
$128.99 CAD
- Series -
- Medicine (R0)
2012
EN
It has been a challenge for us to edit this volume of Endocrinology and Metabo lism: Progress in Research and Clinical Practice. The topic of the pathogenesis of insulin-dependent, type I diabetes mellitus is particularly appropriate for this series, since advances in this area have been made, to a large extent, by applying state-of-the-art laboratory techniques to clinical samples. Over the last several years, a number of lines of evidence have been gathered, suggesting that classic type ...
$64.49 CAD
Origin of Group Identity
Viruses, Addiction and Cooperation
2008
EN
A sense of belonging is basic to the human experience. But in this, humans are not unique. Essentially all life, from bacteria to humans, have ways by which it determines which members belong and which do not. This is a basic cooperative nature of life I call group membership which is examined in this book. However, cooperation of living things is not easily accounted for by current theory of evolutionary biology and yet even viruses display group membership. That viruses have this feature...
$180.69 CAD
- Series -
- Biomedical and Life Sciences (R0)
2009
EN
Androgens are critical regulators of prostate differentiation and function, as well as prostate cancer growth and survival. Therefore, androgen ablation is the preferred systemic treatment for disseminated prostate cancer. Androgen action is exerted in target tissues via binding the androgen receptor (AR), a nuclear receptor transcription factor.Historically, the gene expression program mediated by the AR has been poorly understood. However, recent gene expression profiling and mor...
$180.69 CAD
- Series -
- Medicine (R0)
2013
EN
Over the past decade, significant progress has been made in the theory and applications of pharmacodynamics of antimicrobial agents. On the basis of pharmacokinetic-pharmacodynamic modeling concepts it has become possible to describe and predict the time course of antimicrobial effects under normal and pathophysiological conditions. The study of pharmacokinetic-pharmacodynamic relationships can be of considerable value in understanding drug action, defining optimal dosing regimens, and in ...
$206.49 CAD
- Series -
- Biomedical and Life Sciences (R0)
2009
EN
Muscle disease represents an important health threat to the general population. There is essentially no cure. Gene therapy holds great promise to correct the genetic defects and eventually achieve full recovery in these diseases. Significant progresses have been made in the field of muscle gene therapy over the last few years. The development of novel gene delivery vectors has substantially enhanced specificity and efficiency of muscle gene delivery. The new knowledge on the immune respons...
$232.29 CAD
2013
EN
How will increased understanding of the human genome affect our ability to diagnose and treat disease? The subject of recombinant DNA technology is no longer limited to the research laboratory; it is being discussed in ever-widening medical circles. Introduction to Molecular Medicine is especially written for the physician who is not a genetics expert but wishes to understand this new science and find entry to the more specialized publications. The first chapters present t...
$103.19 CAD
Tumor-Induced Immune Suppression
Mechanisms and Therapeutic Reversal
- Series -
- Biomedical and Life Sciences (R0)
2014
EN
Tumor-Induced Immune Suppression - Prospects and Progress in Mechanisms and Therapeutic Reversalpresents a comprehensive overview of large number of different mechanisms of immune dysfunction in cancer and therapeutic approaches to their correction. This includes the number of novel mechanisms that has never before been discussed in previous monographs.The last decades were characterized by substantial progress in the understanding of the role of the immune system in tumor...
$258.09 CAD
Gene Therapy for HIV
From Inception to a Possible Cure
2014
EN
This Brief describes the concept and realization of gene therapy for HIV from the unique historic perspective and insight of two pioneers of the clinical applications of stem cell gene therapy for HIV.Gerhard Bauer applied ribozyme-anti-HIV and other vectors to manufacture clinical grade, HIV-resistant hematopoietic stem cells for the first patients that received stem cell gene therapy for HIV, including the first child in the world and the first fully marrow-ablated HIV infected p...
$64.49 CAD











